Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnostic and therapeutic programs. Individual development of treatment plans for the treatment and management of biosynthesis-associated antibiotics typically includes pharmacotherapy, rehabilitation interventions, regular follow-up, etc.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat autoimmune and rheumatic immune diseases have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of biosynthetic synthesis synthesis compounds.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.